Transcription factor E2F1 is a major target for RB to exhibit its tumor suppression efficacy, un- or hypo-phosphorylated RB binds to E2F1, leading to the inhibited expression of E2F1 target genes and arrested G1/S cell cycle transition. Here, E2F1 is linked to neoplasm.